Diagnosis of Breast Carcinoma with Radiolabeled Monoclonal Antibodies (MoAbs) to Carcinoembryonic Antigen (CEA) and Human Milk Fat Globulin (HMFG)

References

• Goldenberg D M, De Land F H, Kim E E. Tumor localization of antibodies to CEA. N Engl J Med 1980; 303: 1237–1242
   Web of Science ®Google Scholar
• Larson S M. Radiolabeled monoclonal antitumor antibodies in diagnosis and therapy. J Nucl Med 1985; 26: 538–545
   PubMed Web of Science ®Google Scholar
• Mach J P, Carrel S, Fomi M. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: A critical evaluation. N Engl J Med 1986; 303: 5–10
   Google Scholar
• Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1986; 46: 3225–3238
   PubMed Web of Science ®Google Scholar
• Patt Y Z, Lamki L M, Haynie T P. Improved tumor localization with increasing doses of indium-111 labeled anti-carcino-embryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. J Clin Oncol 1989; 6: 1220–1230
   Web of Science ®Google Scholar
• Goldenberg DM, Kim E E, Bennett S J. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. Gastroenterology 1983; 84: 523–524
   Google Scholar
• Match J P, Chatal I F, Lumbroso J D. Tumor localization in patients by radiolabeled monoclonal antibodies against colon cancer. Cancer Res 1983; 43: 5593–5600
   PubMed Web of Science ®Google Scholar
• Abdel-Nabi H H, Schwartz A N, Higano C S. Colorectal carcinoma: Detection with indium-111 anticarcinoembryonic antigen monoclonal antibody ZCE025. Radiology 1988; 164: 617–621
   Web of Science ®Google Scholar
• Abdel-Nabi H H, Schwartz A N, Goldfogel G. Colorectal tumors: Scintigraphy with In-111-anti CEA monoclonal antibody and correlation with surgical, histopathologic and immuno-histochemical findings. Radiology 1988; 166: 747–752
   PubMed Web of Science ®Google Scholar
• Kuhn JA, Thomas G. Monoclonal antibodies and colorectal carcinoma: A clinical review of diagnostic applications. Cancer Invest 1994; 12: 314–323
   PubMed Web of Science ®Google Scholar
• Kim J A, Triozzi P L, Martin EW, Jr. Radioimmunoguided surgery for colorectal cancer. Oncology 1993; 75–64
   Google Scholar
• Corbisiero R M, Yamauchi D M, Williams L E. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: Individual lesion analysis. Cancer Res 1991; 51: 5704–5711
   PubMed Web of Science ®Google Scholar
• Murray J L, Rosenblum M G, Lamki L. Clinical parameters related to optimal tumor localizations of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018. J Nucl Med 1987; 28: 25–33
   PubMed Web of Science ®Google Scholar
• Wilson B S, Imai K, Natali C A. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 1981; 28: 293–300
   PubMed Web of Science ®Google Scholar
• Halpern S E, Dillman R D, Witztum K F. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: A preliminary report. Radiology 1985; 155: 493–499
   PubMed Web of Science ®Google Scholar
• Saleh M N, Khazaeli M B, Wheeler R H. Phase I trial of the murine monoclonal anti Gd2 antibody 14G2a in metastatic melanoma. Cancer Res 1992; 52: 4342–4347
   PubMed Web of Science ®Google Scholar
• Surwit E A, Childers JM, Krag D N. Clinical assessment of 111 In-CYT-103 immunoscintigraphy in ovarian cancer. Gynecol Oncol 1993; 48: 285–292
   PubMed Web of Science ®Google Scholar
• Shepherd J H, Granowska M, Britton K E. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer. Br J Obstet Gynecol 1987; 94: 160–167
   PubMedGoogle Scholar
• Stems E E, Cochran A J. Monoclonal antibodies in the diagnosis and treatment of carcinomas of the breast. Surg Gynecol Obstet 1989; 169: 81–98
   PubMedGoogle Scholar
• Tjandra J J, McKenzie I F. Murine monoclonal antibodies in breast cancer. An overview. Br J Surg 1988; 75: 1067–1077
   PubMed Web of Science ®Google Scholar
• Thor A D, Edgerton S M. Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applications. Semin Nucl Med 1989; 29: 295–308
   Google Scholar
• Schlom J, Colcher D, Roselli M. Tumor targeting with monoclonal antibody B72.3. Nucl Med Biol 1989; 16: 1237–1249
   Google Scholar
• Burchell J, Durbin H, Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG1 and HMFG2 in normal and malignant human mammary epithelial cells. J Inimunol 1983; 131: 508–513
   PubMed Web of Science ®Google Scholar
• Goldenberg D M, Kim E E, DeLand F M. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980; 40: 2984–2992
   PubMed Web of Science ®Google Scholar
• Smedley H M, Finan P, Lennox E S. Localization of metastatic carcinoma by a radiolabeled monoclonal antibody. Br J Cancer 1983; 47: 253–259
   PubMed Web of Science ®Google Scholar
• Thompson L H, Jones S L, Whitehead R H. A human breast tissue-associated antigen detected by monoclonal antibodies. J Natl Cancer Inst 1983; 70: 409–419
   PubMed Web of Science ®Google Scholar
• Menard S, Tagliabue E, Camevari S. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 1983; 43: 1295–1320
   PubMed Web of Science ®Google Scholar
• Major P, Wang T, Lshida M. Breast cancer imaging with mouse monoclonal antibodies. Eur J Nucl Med 1989; 15: 655–660
   PubMedGoogle Scholar
• Arklie J, Taylor-Papadimitriou J, Bodmer W F. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancer. Int J Cancer 1981; 28: 23–29
   PubMed Web of Science ®Google Scholar
• Colcher D, Hordn H, Nuti M. Differential binding to human mammary and nonniammary tumors of monoclonal antibodies reactive with carcinoembryonic antigens. Cancer Invest 1983; 1: 127–138
   PubMed Web of Science ®Google Scholar
• Nuti M., Teramoto Y A, Manana-Constantmi R. A monoclonal antibody (B 72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell population. Int J Cancer 1982; 29: 539–545
   PubMed Web of Science ®Google Scholar
• Rosenstraus M J, Davis W L, Dwight Lopes A. Immuno-histochemical and pharmacokinetic characterization of site-specific immunoconjugate 15 A8-Glycyl-(M-E-dithylene-triamine penetacetic acid)-lysine derived from anti-breast carcinoma monoclonal antibody 15A8. Cancer Res 1991; 51: 5744–5751
   PubMed Web of Science ®Google Scholar
• Rosner D, Bedwani R N, Vana J. Results of a national survey by the American College of Surgeons. Ann Surg 1980; 192: 139–147
   PubMed Web of Science ®Google Scholar
• Tabor L, Faberberg G, Duffy S W. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30: 187–210
   PubMed Web of Science ®Google Scholar
• Thomas B A, Price J L. The Guilford breast screening project. A 6 year assessment. Recent Results Cancer Res 1987; 105: 67–72
   PubMedGoogle Scholar
• Fisher B, Redmond C, Poisson R. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpec-tomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822–828
   PubMed Web of Science ®Google Scholar
• Veronesi U, Salvardori B, Luini A. Conservative treatment of early breast cancer. Long-term results of 1,232 cases treated with quadranectomy, axillary dissection and radiotherapy. Ann Surg 1990; 211: 250–259
   PubMed Web of Science ®Google Scholar
• Sarrazin D, Le M G, Arriagada R. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 34: 177–184
   Google Scholar
• Blichert-Taft M. A Danish randomized trial cornparing breast conservation with mastectomy in mammary carcinoma. Br J Carcinoma 1990; 62: 15, Suppl 12
   Google Scholar
• Rosner D, Lane W W, Penetrante R. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 1991; 67: 1498–1503
   PubMed Web of Science ®Google Scholar
• Schwartz GP., Patchefsky A S, Finkelstein S D. Nonpalpable in situ ductal carcinoma of the breast: Predictors of rnulticentricity and microinvasion and implications for treatment. Arch Surg 1989; 124: 29–32
   PubMed Web of Science ®Google Scholar
• Lagios M D, Margolin F R, Westdahl P R. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618–624
   PubMed Web of Science ®Google Scholar
• Holland R, Connolly J L, Gelman R. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease with remainder of the breast. J Clin Oncol 1990; 8: 113–118
   PubMed Web of Science ®Google Scholar
• Rosner D, Joshua H, Cutglas H. Le valeur de la ponction biopsique et de l'examen cytologique dans la rddiotherapie preoperatoire du cancer du sein. J Radiol 1964; 11: 691–696
   Google Scholar
• Martin EW, Jr, Mojzisik C M, Hinkle GH, Jr. Radio-immunoguided surgery using monoclonal antibody. Am J Surg 1988; 156: 386–392
   PubMed Web of Science ®Google Scholar
• McEwan Mac A., Lean G, Golberg L. Tc-99 m 170H. 82 (Tm-Scint R AD™): A monoclonal antibody for the evaluation of patients with breast cancer—A preIiminary analysis. (abstract). Current Status and Future Direction of Immunoconjugates, 5th Annual Symposium, Ft Lauderdak, FL, January, 1993, 44
   Google Scholar
• Rosner D, Nabi H, Hreshchyshyn M. Diagnosis of breast carcinoma with radiolabeled monocolonal antibodies to carcinoembryonic antigen and human milk fat globulin. Fifth Annual Symposium, Diagnostic and Therapeutic Applications of Antibodies, University of Miami. 1993, 46
   Google Scholar
• Rosner D, Nabi H, Hreshchyshyn M. Radioimmunodetection of breast carcinoma utilizing radiolabeled monoclonal antibodies to human milk fat globulin and carcinoembryonic antigen (abstract 1185). Proc Am Assoc Cancer Res 1993; 34: 199
   Google Scholar
• Schlom J A, Wunderlick D, Teramoto Y A. Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc Natl Acad Sci USA 1980; 77: 6841–6845
   PubMed Web of Science ®Google Scholar
• Colcher D, Hand P H, Nuti M. A spectrum of monoclonal antibodies receptive with human mammary tumor cells. Proc Natl Acad Sci USA 1981; 78: 3199–3203
   PubMed Web of Science ®Google Scholar
• Yuan D, Hendler F J, Vitetta E S. Characterization of a monoclonal antibody reactive with a subset of human breast tumors. J Natl Cancer Inst 1982; 68: 719–728
   PubMed Web of Science ®Google Scholar
• Iacobbeli S, Natoli V, Scambia G. A monoclonal antibody (AB/3) reactive with human breast cancer. Cancer Res 1985; 45: 4334–4338
   PubMed Web of Science ®Google Scholar
• Perey L, Hayes D F, Maimonis P. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992; 52: 2563–2568
   PubMed Web of Science ®Google Scholar
• Pancino G, Charpin C, Osinaga E. Characterizatiom and distribution in human tissue of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D1. Cancer Res 1990; 50: 7333–7342
   PubMed Web of Science ®Google Scholar
• Pancino G, Charpin C, Calvo F. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast. Cancer Res 1987; 47: 4444–4452
   PubMed Web of Science ®Google Scholar
• Cenani R L, Peterson JA., Lee J Y. Characterization of cell surface antigens of human mammary epthelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet 1983; 9: 415–427
   PubMedGoogle Scholar
• Hilkens J, Buijs F, Hilgers J. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34: 197–206
   PubMed Web of Science ®Google Scholar
• Taylor-Papadimitriou J, Peterson J A, Arklie J. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture. Int J Cancer 1981; 28: 17–21
   PubMed Web of Science ®Google Scholar
• Begent R HJ, Stanway G, Jones B E. Radioimmunolocalization of tumors by external scintigraphy after administration of 131-I antibody to human chorionic gonadotrophin: Preliminary communication. JR Soc Med 1980; 73: 624–630
   PubMed Web of Science ®Google Scholar
• Thompson C H, Lichtenstein M, Stacker S A. Immuno-scintigraphy for detection of lymph node metastases from breast cancer. Lancet 1984; 2: 1245–1247
   PubMed Web of Science ®Google Scholar
• Rainsburg R M, Westwood J M, Coombs R C. Location of metastatic breast carcinomas by monoclonal antibody chelate labeled with indium-111. Lancet 1983; 2: 934–938
   PubMed Web of Science ®Google Scholar
• Nieroda C A, Mojzisik C, Sardi A. Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3. Surg Gynecol Obstet 1989; 169: 35–40
   PubMedGoogle Scholar
• Bradwell A, Dykes P, Thomas G. Antibody targeting: Theoretical considerations. Cancer Imaging with Radiolabeled Antibodies, DM Goldenberg. Kluver Academic Publ., Boston 1991; 11–25
   Google Scholar
• Ryan K P, Dillman R O, DeNardo S J. Breast cancer imaging with In-111 human IGM monoclonal antibodies. Preliminary studies. Radiology 1988; 167: 71–75
   PubMed Web of Science ®Google Scholar
• Bradwell A R, Fairweather D S, Dykes P W. Limiting factors in the localization of tumors with radiolabeled antibodies. Immunol Today 1985; 6: 163–169
   PubMedGoogle Scholar
• Oostenvijk E, Bander N H, Divgi C R. Antibody localization in human renal cell carcinoma: A phase 1 study of monoclonal antibody G250. J Clin Oncol 1993; 11: 738–750
   PubMed Web of Science ®Google Scholar
• Veronesi U, Farante G, Galimberti V. Evaluation of resection margins after breast conservative surgery with monoclonal antibodies. Eur J Surg Oncol 1991; 17: 338–341
   PubMedGoogle Scholar
• Lamki L M, Buzdar A U, Singletary S E. Indium-111-labeled B72–3 monoclonal antibody in the detection and staging of breast cancer. A phase I study. J Nucl Med 1991; 32: 1326–1332
   PubMed Web of Science ®Google Scholar
• Tjandra J J, Russell I S, Collins J P. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer. Cancer Res 1989; 49: 1600–1668
   PubMed Web of Science ®Google Scholar
• Mandeville R, Schatten C, Pateisky N. Immunolympho-scintigraphy with BCD-F9 monoclonal antibody and its F(AB1) 2 fragments for the preoperative staging of breast cancer. Breast Cancer Immunodiagnosis and Immunotherapy, RL Ceriani. Plenum Press, New York 1989; 203–210
   Google Scholar
• Kairemo K J. Immunolymphoscintigraphy with 99 MTC-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer. Cancer Res 1990; 50: 949–954, (Suppl 3)
   PubMed Web of Science ®Google Scholar
• Athanasiou A, Pectasides D, Patenoitis K. Immunoscintigra-phy with 131-l labeled HMFG 2 and HMFG 1 F (AB1) 2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients. Int J Cancer 1988; 88–95, (Suppl 3)
   Google Scholar
• Prey M U, Bedrossian C W, Masood S. The value of monoclonal antibody B72.3 for the diagnosis of breast carcinoma: Experience with the first commercially available source. Hum Pathol 1991; 22: 598–602
   PubMed Web of Science ®Google Scholar
• Epenetos A A, Britton K E, Mather S. Targeting of iodine-123 labeled tumor associated monoclonal antibodies to ovarian, breast and gastrointestinal tumors. Lancet 1982; 2: 999–1004
   PubMed Web of Science ®Google Scholar
• Kalofonos H P, Sackier J M, Hatzistylianou M. Kinetics, quantitative analysis and radioimmunoiocaiization using Indium-111-HMF1 monoclonal antibody in patients with breast cancer. Br J Cancer 1989; 59: 939–942
   PubMed Web of Science ®Google Scholar
• Lind P, Smola M G, Lechner P. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. int J Cancer 1991; 47: 865–869
   PubMed Web of Science ®Google Scholar
• Rosner Nabi D. H. Potential use of radioimmunodetection in diagnosis and management of breast carcinoma. Sixth Annual Symposium. Diagnostic and Therapeutic Application of Radiolabeled Antibodies and Receptors for Diagnostic and Therapeutic Purposes, University of Miami. 1994, 96, (abstract)
   Google Scholar